Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine deaminase inhibitor, in the rat formalin test

Pain

Volumn 74, Issue 1, 1998, Pages 75-81

  Sawynok, Jana ^a   Reid, Allison ^a   Poon, Anthony ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine A1 receptor; Adenosine deaminase; Adenosine kinase; Antinociception; Formalin test

Indexed keywords

3,7 DIMETHYL 1 PROPARGYLXANTHINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE DEAMINASE INHIBITOR; ADENOSINE KINASE INHIBITOR; CAFFEINE; DEOXYADENOSINE DERIVATIVE; DIMETHYL SULFOXIDE; DRUG VEHICLE; FORMALDEHYDE; PENTOSTATIN; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADENOSINE DEAMINASE; ADENOSINE KINASE; ANIMALS; DEOXYADENOSINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INJECTIONS, SUBCUTANEOUS; MALE; PAIN; PAIN MEASUREMENT; PENTOSTATIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031884745     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(97)00153-X     Document Type: Article

References (44)

1. Agarwal R.P., Spector T., Parks R.E. Tight-binding inhibitors - IV. Inhibition of adenosine deaminases by various inhibitors. Biochem. Pharmacol. 26:1977;359-367.
2. Aley K.O., Green P.G., Levine J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15:1995;8031-8038.
3. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
4. Cronstein B.N. A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites. J. Invest. Med. 43:1995;50-57.
5. Cronstein B.N., Naime D., Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J. Clin. Invest. 92:1993;2675-2682.
6. Cronstein B.N., Naime D., Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthrit. Rheum. 38:1995;1040-1045.
7. Doak G.J., Sawynok J. Complex role of peripheral adenosine in the genesis of the response to subcutaneous formalin in the rat. Eur. J. Pharmacol. 281:1995;311-318.
8. Doak, G.J. and Sawynok, J., Formalin-induced nociceptive behaviour and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes, Neuroscience, 80 (1997) 939-949.
9. Dolphin A.C., Forda S.R., Scott R.H. Calcium-dependent currents in cultured rat dorsal root ganglion neurones are inhibited by an adenosine analog. J. Physiol. 373:1986;47-61.
10. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 75:1995;125-131.
11. Franco R., Canela E., Bozal J. Heterogeneous localization of some purine enzymes in subcellular fractions of rat brain and cerebellum. Neurochem. Res. 11:1986;423-435.
12. 1 receptors. J. Am. Coll. Cardiol. 25:1995;251-257.
13. Gaspardone, A., Crea, F., Tomai, F., Lamele, M., Crossman, D.C., Pappagallo, M., Versaci, F., Chiariello, L. and Gioffrè, P.A., Substance P potentiates the algogenic effects of intraarterial infusion of adenosine, J. Am. Coll. Cardiol., 24 (1994) 477-482.
14. Geiger J.D., LaBella F.S., Nagy J.I. Characterization and localization of adenosine receptors in rat spinal cord. J. Neurosci. 4:1984;2303-2310.
15. Golembiowska K., White T.D., Sawynok J. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res. 699:1995;315-320.
16. Golembiowska K., White T.D., Sawynok J. Adenosine kinase inhibitors augment release of adenosine from spinal cord slices. Eur. J. Pharmacol. 307:1996;157-162.
17. Hourani S.M.O., Hall D.A. Receptors for ADP on human blood platelets. Trends Pharmacol. Sci. 15:1994;103-108.
18. Karlsten R., Gordh T., Post C. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol. Toxicol. 70:1992;434-438.
19. Keil G.J., DeLander G.E. Spinally-mediated antinociception is induced in mice by an adenosine kinase-, but not by an adenosine deaminase-, inhibitor. Life Sci. 51:1992;171-176.
20. Khasar S.G., Wang J.F., Taiwo Y.O., Heller P.H., Green P.G., Levine J.D. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein βγ subunit-mediated effect? Neuroscience. 67:1995;189-195.
21. Levine, J. and Taiwo, Y., Inflammatory pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, 3rd edn., Churchill Livingstone, London, 1994, pp. 45-56.
22. Lloyd H.G.E., Fredholm B.B. Involvement of adenosine deaminase and adenosine kinase in regulating extracellular adenosine concentration in rat hippocampal slices. Neurochem. Int. 26:1995;387-395.
23. Meghi, P., Adenosine production and metabolism. In: T. Stone (Ed.), Adenosine in the Nervous System, Academic Press, London, 1991, pp. 25-42.
24. Miller R.L., Adamczyk D.L., Miller W.H., Koszalka G.W., Rideout J.L., Beacham L.M., Chao E.Y., Haggerty J.J., Krenitsky T.A., Elion G.B. Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity. J. Biol. Chem. 254:1979;2346-2352.
25. Murray T.F., Zhang G., Franklin P.H. Manipulation of endogenous adenosine affects seizure susceptibility. Drug. Dev. Res. 28:1993;410-415.
26. Padua R., Geiger J.D., Dambock S., Nagy J.I. 2′-Deoxycoformycin inhibition of adenosine deaminase in rat brain: in vivo and in vitro analysis of specificity, potency, and enzyme recovery. J. Neurochem. 54:1990;1169-1178.
27. Pak M.A., Hass H.L., Decking U.K.M., Schrader J. Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices. Neuropharmacology. 33:1994;1049-1053.
28. Pappagallo M., Gaspardone A., Tomai F., Iamele M., Crea F., Cioffré P.A. Analgesic effect of bamiphylline on pain induced by intradermal injection of adenosine. Pain. 53:1993;199-204.
29. Poon A., Sawynok J. Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration. Eur. J. Pharmacol. 286:1995;177-184.
30. Poon A., Sawynok J. Spinal analgesia by adenosine agonists and inhibitors of adenosine metabolism, with synergy between an adenosine kinase and an adenosine deaminase inhibitor. Br. J. Pharmacol. 119(Suppl.):1996;204P.
31. Poon, A., Sawynok, J., Allen, G.V. and Esser, M.J., Local antiinflammatory and systemic antinociceptive effect produced by a combination of adenosine kinase and adenosine kinase inhibitors, Soc. Neurosci. Abstr., 23 (1997) 1814.
32. Rosengren S., Bong G.W., Firestein G.S. Anti-inflammatory effects of an adenosine kinase inhibitor. Decreased neutrophil accumulation and vascular leakage. J. Immunol. 154:1995;5444-5451.
33. 1 receptors mediate the presynaptic inhibition of calcitonin gene-related peptide release by adenosine in the rat spinal cord. Eur. J. Pharmacol. 231:1993;139-142.
34. Sawynok, J., Purines and nociception. In: K.A. Jacobson and M.F. Jarvis (Eds.), Purinergic Approaches in Experimental Therapeutics, Wiley-Liss, New York, 1997, pp. 495-513.
35. 3 receptor activation produces nociceptive behaviour and edema by release of histamine and 5-hydroxytryptamine, Eur. J. Pharmacol., 333 (1997) 1-7.
36. 2 receptors. Eur. J. Pharmacol. 298:1996;105-111.
37. Sciotti V.M., Van Wylen D.G.L. Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine deaminase. J. Cerebral Blood Flow Metab. 13:1993;201-207.
38. Taiwo Y.O., Levine J.D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 38:1990;757-762.
39. Taiwo Y.O., Levine J.D. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience. 44:1991;131-135.
40. Tjølsen A., Berge O.-G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
41. White T.D. Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine. Eur. J. Pharmacol. 303:1996;27-38.
42. White, T.D. and Hoehn, K., Release of adenosine and ATP from nervous tissue. In: T.W. Stone (Ed.), Adenosine in the Nervous System, Academic Press, London, 1991, pp. 173-195.
43. Williams M. Progress towards purinoceptor based therapeutics. Curr. Opin. Invest. Drugs. 2:1993;1105-1117.
44. Zhang G., Franklin P.H., Murray T.F. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. J. Pharmacol. Exp. Ther. 264:1993;1415-1423.